ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,697.35
0.64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nivalis Therapeutics, Inc. (MM) (NVLS)

  7. Nivalis Therapeutics, Inc. (MM) (NVLS) News

NIVALIS THERAPEUTICS, INC. (NVLS)

Nivalis Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVLS
DateTimeSourceHeadlineSymbolCompany
11/09/201721:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
22/08/201722:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
03/08/201721:32Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
03/08/201719:18Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
31/07/201711:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
28/07/201721:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
28/07/201720:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
27/07/201722:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
26/07/201722:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLSNivalis Therapeutics, Inc. (MM)
11/02/201014:00PR Newswire (US)Novellus Systems, IBM and the UAlbany NanoCollege Establish Strategic Partnership at CNSE's Albany NanoTech ComplexNASDAQ:NVLS
01/02/201021:05PR Newswire (US)Novellus Systems Ships 1000th VECTOR(R) PECVD SystemNASDAQ:NVLS
20/01/201014:00PR Newswire (US)Novellus Announces Availability and Timing of Fourth Quarter and Year-End 2009 Financial Results WebcastNASDAQ:NVLS
13/01/201021:05PR Newswire (US)Novellus Systems Launches SOLA(R) xT UVTP System For Sub-45nm High Volume ManufacturingNASDAQ:NVLS
20/11/200914:31PR Newswire (US)Critical Alerts for Chevron, Bristol-Myers Squibb, Gold Fields, Novellus, and Host Hotels Released by Seven Summits ResearchNASDAQ:NVLS
05/11/200914:00PR Newswire (US)Novellus Announces Availability and Timing of Mid-Quarter Update Conference Call Webcast for Fourth Quarter 2009NASDAQ:NVLS
03/11/200921:05PR Newswire (US)Novellus Improves Tungsten Resistivity Performance With Advanced LRWxT(TM) ProcessNASDAQ:NVLS
 Showing the most relevant articles for your search:NASDAQ:NVLS

Your Recent History

EU
BE0002634153
Region de Bruxelles Capi...
TSX
VLE
Valeura Energy
NYSE
IQV
IQVIA
EU
FR0011129204
Domo SA DOMOSBAFRNSEP2060
BIT
P1ELH5
BNP Paribas Issuance
NASDAQ
FHOPVX
Diversified Fixed Income...
BIT
WDESG
Exchange Traded Fund Csi...
BIT
I08671
Intesa Sanpaolo
BIT
UC7PXR
Unicredit Bank
LSE
FD96
Snb Fund 30
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved